BACKGROUND: Preterm birth is the leading cause of newborn death worldwide, and is associated with significant cognitive and physiological challenges in later life. There is a pressing need to define the mechanisms that initiate spontaneous preterm labor, and for development of novel clinical biomarkers to identify high-risk pregnancies. Most preterm birth studies utilize fetal tissues, and there is limited understanding of the transcriptional changes that occur in mothers undergoing spontaneous preterm labor. Earlier work revealed that a specific population of maternal peripheral leukocytes (macrophages/monocytes) play an active role in the initiation of labor. Thus, we hypothesized that there are dynamic gene expression changes in maternal blood leukocytes during preterm labor. OBJECTIVE: Using next-generation sequencing we aim to characterize the transcriptome in whole blood leukocytes and peripheral monocytes of women undergoing spontaneous preterm labor compared to healthy pregnant women who subsequently delivered at full term. STUDY DESIGN: RNA sequencing was performed in both whole blood and peripheral monocytes from women who underwent preterm labor (24-34 weeks of gestation, N ¼ 20) matched for gestational age to healthy pregnant controls (N ¼ 30). All participants were a part of the Ontario Birth Study cohort (Toronto, Ontario, Canada). RESULTS: We identified significant differences in expression of 262 genes in peripheral monocytes and 184 genes in whole blood of women who were in active spontaneous preterm labor compared to pregnant women of the same gestational age not undergoing labor, with 43 of these genes differentially expressed in both whole blood and peripheral monocytes. ADAMTS2 expression was significantly increased in women actively undergoing spontaneous preterm labor, which we validated through digital droplet reverse transcriptase polymerase chain reaction. Intriguingly, we have also identified a number of gene sets including signaling by stem cell factor-KIT, nucleotide metabolism, and trans-Golgi network vesicle budding, which exhibited changes in relative gene expression that was predictive of preterm labor status in both maternal whole blood and peripheral monocytes. CONCLUSION: This study is the first to investigate changes in both whole blood leukocytes and peripheral monocytes of women actively undergoing spontaneous preterm labor through robust transcript measurements from RNA sequencing. Our unique study design overcame confounding based on gestational age by collecting blood samples from women matched by gestational age, allowing us to study transcriptomic changes directly related to the active preterm parturition. We performed RNA profiling using whole genome sequencing, which is highly sensitive and allowed us to identify subtle changes in specific genes. ADAMTS2 expression emerged as a marker of prematurity within peripheral blood leukocytes, an accessible tissue that plays a functional role in signaling during the onset of labor. We identified changes in relative gene expression in a number of gene sets related to signaling in monocytes and whole blood of women undergoing spontaneous preterm labor compared to controls. These genes and pathways may help identify potential targets for the development of novel drugs for preterm birth prevention.
Introduction
Preterm birth (PTB) is the leading cause of newborn death worldwide, is responsible for the majority of newborn morbidity, 1 and represents a significant financial and social burden to caregivers and health care systems. Approximately 40% of PTB results from spontaneous preterm labor (sPTL) and excludes premature membrane rupture or medically indicated births.
2 Despite significant research efforts, the underlying mechanisms responsible for the initiation of sPTL remain elusive.
Accurate prediction of sPTL is difficult due to its multifactorial etiology. Cervical length, fibronectin, and history of sPTL are used to predict sPTL. 3 Cervical length has been associated with spontaneous PTB 4, 5 and is predictive of sPTL with a specificity of 33-54% and sensitivity of 73-91%. 6 Cervicovaginal fibronectin is predictive of sPTL in asymptomatic women with a specificity of 85-90% and sensitivity of 59-71%. 7 The low sensitivity and short time frame of these methods limits their clinical efficacy.
8 Models incorporating both fibronectin and cervical length provide higher predictive accuracy of sPTL in asymptomatic women. 3 As there are limited options for the identification of women who are delivering spontaneously, there are also limited treatments for women with sPTL, including vaginal progesterone or hydroxyprogesterone caproate. In a large double-blind trial, hydroxyprogesterone caproate emerged as a promising treatment that significantly reduced the risk of PTB, 9 but subsequent prospective analysis revealed no Original Research ajog.org benefit of this drug and increased risk of gestational diabetes. 10 Transcriptomics have been successful for diagnosis and treatment of common diseases such as cancer, 11 heart failure, 12 cardiovascular disease, 13 and inflammatory lung disease, 14 and there is growing interest in using these technologies in the context of sPTL. 15 Generation and analysis of high-dimensional data is proposed to overcome many of the challenges inherent in this field.
16 Highthroughput proteomics were used to generate a molecular screen predictive of sPTL as early as 15 weeks into pregnancy with 75% accuracy. 17 There are limited transcriptomics analyses of sPTL, including only 18% of pregnancy transcriptomic studies. 16 Transcriptomics provide additional insight into molecular mechanisms occurring in women who deliver prematurely as well as enhanced predictive capacity.
Dynamic changes in the immune system occur throughout pregnancy that are detectable in blood. Monocytes/ macrophages are involved in placental invasion, angiogenesis, and tissue remodeling. 18 Maternal peripheral monocytes (PM) increase throughout pregnancy and differentiate into an antiinflammatory M2 phenotype during uterine tissue infiltration. 19 The ratio of proinflammatory M1 and antiinflammatory M2 macrophages is altered in complicated pregnancies. 18 Labor is a localized inflammatory process resulting in elevated levels of maternal circulating leukocytes, 20 which reflect physiological changes in the uterus during labor. 21 Increased leukocyte counts are predictive of preterm labor (PTL) in women with ruptured membranes at 22-27 weeks' gestation.
22 sPTL is associated with phenotypic and metabolic changes in maternal granulocytes and monocytes 23 and increased cytokine messenger RNA (mRNA) production. 24 Ex vivo chemotaxis assays performed in animal models and immunophenotyping of peripheral leukocytes from pregnant women indicate that maternal immune cells are primed in peripheral blood in preparation for labor, 25, 26 exhibit chemotactic responsiveness, and are recruited to the uterus prior to and during labor. 20 Maternal peripheral blood (whole blood [WB] ) is easily accessible, making it an attractive source to study pregnancy-associated transcriptional modifications. Gene expression profiling in maternal WB collected in early pregnancy is predictive of PTB in symptomatic and asymptomatic women, 27, 28 suggesting that circulating maternal peripheral leukocytes act as the body's biosensors.
There is a research gap in our understanding of transcriptional changes that occur in women experiencing sPTL. We hypothesized that dynamic transcriptomics changes occur in maternal WB leukocytes during sPTL, which are enhanced in the subpopulation of PM. Our objective was to characterize transcriptomic differences in WB and of PM between women undergoing sPTL at 24-34 weeks of gestation (N ¼ 20) compared to healthy pregnant women matched for gestational age (N ¼ 30) who subsequently delivered at term.
Materials and Methods

Study design
Women involved in this study were from a subpopulation of the Ontario Birth Study (OBS) , an open, continuously enrolling prospective cohort at Mount Sinai Hospital in Toronto, Ontario, Canada. Study design is included in Supplemental Figure 1 . Inclusion criteria for the OBS included pregnancy diagnosed <17 weeks, maternal age >18 years, English speaking, signed informed consent, and intent to deliver and receive antenatal care at Mount Sinai Hospital. Exclusion criteria included nonviable neonate and/or inability to provide consent. This study represents an analysis of a subpopulation of the OBS who were continuously recruited from June 2014 through June 2015, consisting of approximately 1200 patients. Twenty patients who exhibited signs of labor between 24-34 weeks of gestation based on presentation of uterine contractions and cervical dilation >4 cm were identified as sPTL. These patients were matched to a subpopulation of 30 women from the OBS whose blood was taken at the same time point (gestational age), who went on to deliver at term (>37 weeks). Exclusion criteria for cases and controls included antepartum hemorrhage, clinical chorioamnionitis, fetal anomaly, preeclampsia, intrauterine growth restriction, diabetes mellitus, multiple pregnancy, or gestational diabetes. At the time of sample collection, none of the women reported being current smokers. This study was approved by the Research Ethics Board of Mount Sinai Hospital, Toronto, Ontario, Canada (no. 04-0024-E). All patients provided written consent as part of the GAPPS (Global Alliance to Prevent Preterm Birth) cohort at Sinai Health System, Toronto, Ontario, Canada.
Specimen collection
In PTL patients, peripheral blood samples were collected prospectively at the point of hospital admission, and in term labor controls blood was collected during the regular antenatal visit. Blood was collected into both PAXgene tubes (Qiagen, Hilden, Germany) and EDTA blood collection tubes for monocyte separation. Monocytes were separated through the monocyte RosetteSep cocktail (catalog no. 15068; Stemcell Technologies, Vancouver, British Columbia, Canada) , which uses high-density gradient centrifugation to generate a highly purified and stable monocyte fraction for subsequent mRNA isolation.
RNA sequencing
WB RNA was isolated using a PAXgene blood RNA kit (catalog no. 762165; Qiagen), and from PM using TRIzol LS (Invitrogen, Carlsbad, CA) following manufacturer's instructions. RNA quality was determined using Experion analyzers (BioRad, Mississauga, Ontario, Canada) 
Statistical analyses
Differentially expressed mRNAs were identified through generalized linear models within EdgeR, a popular tool for RNA sequencing analysis. 30 We employed the Benjamini-Hochberg (BH) method to estimate false discovery rate and correct for multiple comparisons.
32 mRNAs were considered significantly associated with sPTL if they exhibited a BH-adjusted P value of <.05, and a log2 fold change of >1. Network dysregulation was identified using differential rank conservation (DIRAC).
33 DIRAC is a pathway analysis tool that identifies gene sets with significant changes between cases and controls based on changes in rank in defined gene sets. It uses these differences observed in relative gene expression within gene sets between cases and controls to predict case/ control status in new samples. Statistical significance was evaluated using permutation testing (P values) and reproducibility evaluated through leaveone-out cross-validation (LOOCV), where the gene network rankings of all but 1 sample are used to predict expression of the remaining sample. Gene sets were defined using reactome pathway database, a curated and peerreviewed database of human biological pathways. 34 Gene sets were considered significant with a BH-adjusted P value of <.05, and a LOOCV accuracy of >0.8. We identified differentially expressed genes within significant pathways using t tests.
Using publicly available transcriptomics data (GSE61880 35 ), we characterized gene expression of monocyte-derived macrophages treated with 100 nmol/L dexamethasone over 24 hours. Raw data were RMA (robust multi-array average) normalized and log2 transformed. We created a reduced data set consisting of only the differentially expressed genes associated with PTL in WB and PM in the OBS patients (N ¼ 403 genes). We calculated differences in gene expression from baseline at each time point (1, 2, 4, 10, and 24 hours after treatment) using t tests, adjusted for multiple comparisons using the BH method.
29 Data were analyzed and visualized in R (Version 3.3.1) and Cytoscape (Version 3.2.1) 36 using the reactome FIViz Cytoscape plugin. 37 ddPCR validation of target mRNAs ddPCR validation was performed in 38 monocyte samples and 48 WB samples. Complementary DNA (cDNA) was generated from 250 ng of RNA from each blood sample using the iScript gDNA (genomic DNA) clear cDNA synthesis kit (catalog no. 1725034; BioRad). cDNA was amplified using standard protocols 38 ; reactions containing 25 ng cDNA, 250 nmol/L primers, and 1Â QX200 ddPCR EvaGreen Supermix (catalog no. 1864033; BioRad) were generated. Primer sequences are available in Supplemental Table 2 . Droplets were generated from 20 mL of master mix using the QX200 auto droplet generator (BioRad) following instruments settings. Droplet reactions were amplified in a polymerase chain reaction (PCR) cycler for 40 cycles according to the QX200 manual and analyzed on the QX200 droplet reader (BioRad). Results are obtained as absolute numbers of cDNA copies/mL of the initial 20 mL master mix. Technical duplicates were performed for each target and ADAMTS2 expression was normalized to geometric mean of expression for reference genes SDHA (succinate dehydrogenase complex flavoprotein subunit ajog.org
OBSTETRICS Original Research
A), TBP (TATA-box binding protein), and HPRT (hypoxanthine phosphoribosyltransferase 1). Nontemplate controls were included to estimate background counts for specific targets. The detection limit for ADAMTS2 expression was >20 copies/25 ng of cDNA input.
Results
Population characteristics
We compared demographic characteristics of women undergoing sPTL and healthy women who delivered at full term (Table 1) . There were no significant differences in fetal sex, maternal age, or ethnicity between sPTL cases and controls (P > .05, Fisher exact test). Women undergoing sPTL were more likely to deliver vaginally compared to women who delivered at term (P ¼ .003).
Differential gene expression
We identified 403 differentially expressed genes in peripheral blood of women undergoing PTL and gestational agee matched controls using generalized linear models within EdgeR. 30 In PM, 196 genes were up-regulated and 66 genes down-regulated in women undergoing PTL (Figure 1, A) . In WB, 160 genes were up-regulated and 24 genes were downregulated in women undergoing PTL (Figure 1, B) . A total of 39 mRNAs were positively associated with PTL in both WB and PM (Figure 1 , C, and Supplemental Table 3 ). These included inflammatory genes CXCL3 (Chemokine C-X-C-motif Ligand 3), CXCL8 (Chemokine C-X-C motif Ligand 8), IL1B (Interleukin 1 beta), IL18R (Interleukin 18 receptor) and IL1R2 (Interleukin 1 receptor type 2).
Validation of ADAMTS2 expression
ADAMTS2 was among the top 10 genes associated with sPTL in both WB and PM. ADAMTS2 exhibited 5.0-fold increased expression in PM and 3.9-fold increased expression in WB of women in sPTL (Supplemental Table 3 ). ADAMTS2 was not highly expressed in all patients (Figure 2) (Figure 2 , E and F). We concluded that although ADAMTS2 exhibits low read counts, RNA sequencing is concordant with ddPCR expression and based on these cutoffs, ADAMTS2 expression can be reliably measured only in sPTL patients.
Glucocorticoid response in monocyte-derived macrophages
The majority of women who delivered prematurely (13/15 sPTL) were administered corticosteroids prior to labor, but no women who went on to term labor Differential gene expression analysis in monocytes and whole blood MA plot of log2 fold changes vs mean of normalized counts in regularized logarithmic distribution of RNA sequencing data in A, monocytes and B, whole blood (WB). An MA plot is a graphical representation for visualizing differential gene expression data, where A (X axis) reflects the normalized count data, and M stands for the binary log fold change. Messenger RNAs significantly different in linear models after adjustment for multiple comparisons (red) and log2 fold changes >1 (blue lines). C, Venn diagram of overlapping differently expressed genes between monocytes and WB. In all, 43 genes differentially expressed in both WB and monocytes (red in A and B) are shown below Venn diagram. Up-regulated (blue text background) or down-regulated (red text background) in preterm labor in both monocytes and WB, and differences in directionality of association between WB and monocytes (gray text background). (Table 1) . Corticosteroids were administered 6 hours to 34 days before the blood draw, with 7/13 women treated 6-24 hours before blood collection. Since none of the women who delivered at term were treated with synthetic glucocorticoids, this could not be controlled for a stratified or adjusted model, limiting our ability to remove corticosteroid treatment as a confounding variable. To circumvent this, we characterized in vitro corticosteroid response in monocyte-derived macrophages over a 24-hour time period from publicly available data GSE61880 35 within the 403 differentially expressed genes identified in WB leukocytes and PM in RNA sequencing data (Figure 1, C) . In all, 350/403 genes were present on the Affymetrix U133 array (Affymetrix, Santa Clara, CA) (Supplemental Table 4 ), and 300/350 genes (86%) exhibited no significant changes in response to dexamethasone treatment at any time between 4-24 hours compared to baseline (BH-adjusted P <.05, t test) (Supplemental Figure 2, A) . We observed significant changes in gene expression in 14% of the genes, mostly occurring between 0-4 hours of dexamethasone treatment (37 genes) or between 0-24 hours of treatment (29 genes) (Supplemental Figure 2 , B, and Supplemental Table 4 ).
Gene set deregulation
We examined changes in pathways in WB and PM of women who underwent PTL compared with controls. Relative differences in gene expression sets were calculated using DIRAC, 33 using gene sets defined by the Reactome pathway database. 34 We identified 19 pathways in PM and 64 pathways in WB that were significantly perturbed in women experiencing sPTL ( Figure 3 and Supplemental Table 5 ) (BH-adjusted P < .05, LOOCV accuracy >0.8). Three specific gene sets were significantly different in both WB and PM of women in sPTL, including signaling by stem cell factor (SCF)-KIT, nucleotide metabolism, and trans-Golgi network vesicle budding (Figure 3) .
The SCF-KIT signaling pathway exhibited the most reproducible network regulation changes in both WB and PM. We observed significant changes in gene expression of 12/68 genes in this gene set in PM and WB of women undergoing sPTL. These 12 genes were adjacent to many other genes within this gene set, representing critical hubs intimately connected within this pathway (Figure 4 ). In PM, 1 gene (KIT) was significantly lower and 7 genes were significantly higher during sPTL (BHadjusted P < .05). In WB, 2 genes were significantly lower and 2 genes were significantly higher during PTL (BHadjusted P < .05) (Supplemental Figure 3) .
Comment
Principal findings of study
In this study, we identified transcriptomic changes associated with sPTL in maternal WB and PM using nextgeneration RNA sequencing, filling a critical gap in our understanding of transcriptional regulation of labor induction. Principal findings of this study included: (1) identification of 403 ADAMTS2 expression quantified through droplet digital PCR and RNA Sequencing ADAMTS2 transcripts quantified through counts within nonnormalized counts from A and B, RNA sequencing data and C and D, relative droplet digital polymerase chain reaction (ddPCR) expression. E and F, ADAMTS2 expression in samples with matched RNA sequencing and ddPCR RNA quantification. Spearman correlations were performed to examine relationships between ddPCR and RNA sequencing values for both whole blood (WB) (P ¼ 8.12 Â 10 e6 , r ¼ 0.66) and monocytes (P ¼ .05, r ¼ 0.37). Preterm (orange dots) and term (blue dots) samples. Dashed grey line shows correlation. ajog.org OBSTETRICS Original Research differentially expressed mRNAs in WB leukocytes and in PM in women actively undergoing sPTL, including known inflammatory markers; (2) increased ADAMTS2 expression in PM and WB in women undergoing sPTL (validated through ddPCR); and (3) 3 reactome gene sets in both WB and PM associated with sPTL, identified using DIRAC.
Results in context
We identified 262 differentially expressed genes in PM and 184 genes in WB in women who were in active sPTL compared to pregnant women at the same gestational age not undergoing labor. In all, 43 of these genes were differentially expressed in both WB and PM, including cytokines/chemokines (CXCL2 and CXCL8), and their receptors, IL1R2, IL18R1. Increased expression of IL signaling genes was observed at 18 weeks in WB leukocytes of asymptomatic women who subsequently delivered prematurely, 28 and changes in IL signaling were identified within the uterine cervix following sPTL.
39 Thus, our findings are complementary to this previous work.
Women at imminent risk of PTL are often administered synthetic glucocorticoids, including 90% of the women in this study. We examined the impact of dexamethasone on expression of the 403 differentially expressed genes identified in our sPTL cases using publicly available monocyte data. The vast majority of genes associated with sPTL were not impacted by glucocorticoid exposure (86%). The 14% of genes with differential expression following treatment included known inflammatory genes (IL1R, CXCL2, and IRS2) and glucocorticoid response genes (FKBP5). While we cannot conclude that changes in gene expression are not related to steroid administration, we confirm that almost all changes in gene expression that related to active sPTL are not associated with direct glucocorticoid activation in monocytes within 24 hours. Our study was not designed to characterize response to corticosteroid exposure and further research is required to confirm this conclusion and determine if the causality of the changes in expression in these differentially expressed genes was glucocorticoid response.
Research implications
Prior spontaneous PTB studies characterized transcriptomics changes largely within the placenta. 16, 40 There are limited microarray-based analyses of maternal WB related to sPTL 28 or threatened PTL. 27 This study is the first to investigate changes in both WB leukocytes and PM of women actively undergoing sPTL through robust transcript measurements from RNA sequencing. We observed stronger signals from PM than WB, likely related to monocytic activation in pregnancy.
19 During labor, the myometrium secretes cytokines (IL18, CXCL2, CXCL8), that coincide with an influx of monocytes into uterine tissues.
41 These same cytokines (CXCL2, CXCL8, and IL1B) exhibited increased expression in both WB and PM of women undergoing active sPTL in our study, which may reflect transcriptional changes occurring as PM become activated during labor. This indicates that transcriptomics analyses in subpopulations of peripheral leukocytes (PM) may be more informative than in WB, where these signals may be diluted.
Women undergoing active sPTL displayed changes in relative gene expression within 19 gene sets in PM and 64 in WB leukocytes, which included pathways involved in signaling. This may reflect a response to paracrine and hormonal signals, or be related to signaling from PM activation during labor. 25 In both PM and WB, we observed changes within SCF-KIT signaling, nucleotide metabolism, and the trans-Golgi network vesicle budding pathways. SCF-KIT is a growth factor pathway that is expressed in fibroblasts and endothelial cells, which regulate the proliferation of these cells. 42 In pregnancy, the SCF-KIT signaling pathway regulates placental hematopoietic cell proliferation. 42 Mutations in the KIT locus do not alter the timing of normal term delivery 43 but results in altered response to bacterial mimetic lipopolysaccharide 44 and thus potentially could impact the onset of infection-mediated PTL. We speculate that the deregulation of the SCF-KIT signaling pathway observed in women actively undergoing sPTL may be reflective of an infection-related inflammatory process, or related to proliferation of neutrophils that occurs during cervical ripening.
45
Clinical implications
We observed dramatically increased ADAMTS2 expression in WB leukocytes and PM in women undergoing sPTL compared to healthy nonlabor controls. ADAMTS2 is part of a family of metalloproteinases that regulate blood vessel homeostasis, 46 are involved in placental angiogenesis, 47 and are associated with a variety of reproductive diseases. 47 Genetic polymorphisms of other matrix metalloproteinases (MMP) (MMP1, MMP8, MMP9) have been associated with increased risk of PROM (premature rupture of membranes), 48 and amniotic MMP8 protein is a clinical biomarker of intraamniotic infection-related PTL. 49 We were able to detect these subtle changes in ADAMTS2 expression due to the exquisite sensitivity of RNA sequencing to detect low-expressing transcripts, which could not be captured through microarray.
50 Our results suggest PM or WB ADAMTS2 expression could also serve as a noninvasive clinical test of sPTL. Proteomic measurements and validation in an independent population is needed to validate this, which was beyond the scope of our study.
Systems biology is an attractive means to understand and predict sPTL in asymptomatic women as it can capture global changes underlying complex conditions. 48 DIRAC predicts case/control status based on changes in relative gene expression within gene sets defined using reactome. 33 In 3 gene sets, relative gene expression could be used to predict sPTL with >80% accuracy using LOOCV within our cohort. In cancer studies, DIRAC has been used for classification with comparable predictive accuracy to machine learning algorithms. 31 This approach identified differences in key molecular pathways based on prior biological knowledge, which could result in a targeted biomarker panel. Like other machine learning algorithms DIRAC has been used to accurately predict case/control status in very large data sets; however, we cannot robustly assess the predictive accuracy or evaluate the specificity and sensitivity in this study due to limited sample size. This preliminary analysis Functional interaction network of SCF-Kit signaling pathway Functional interaction network of stem cell factor (SCF)-KIT pathway visualized using ReactomeFI Cytoscape plug in. A, All genes in pathway are represented (68 genes): genes increased (blue) and decreased (red) in preterm labor (PTL). Genes significant in monocytes (hexagon) and in whole blood (WB) (diamond). Directionality of network edges are defined within ReactomeFI annotation, with predicted edges (dotted lines). B, Same network subsetted to only include significantly differentially expressed genes (12 genes).
DEG, differently expressed gene; PM, peripheral monocyte; PTK, preterm labor; WB, whole blood.
Paquette et al. Transcriptional changes in whole blood and monocytes during preterm labor. Am J Obstet Gynecol 2018.
FIGURE 3
Results of differential rank conservation
A, Venn diagram of overlapping reactome pathways identified as significantly perturbed using differential rank conservation (DIRAC) in monocytes and whole blood (WB) (Benjamini-Hochberg [BH]-adjusted P < .05, cross-validation accuracy >0.8). B, DIRAC leave-one-out (LOO) cross-validation (CV) accuracy of results of 3 overlapping pathways with monocyte cross-hatched left and WB crosshatched vertically. Depth of coloring indicates strength of association using P values derived from DIRAC and adjusted for multiple comparisons using BH method. ajog.org OBSTETRICS Original Research uses accuracy as a threshold for gene set selection, but a true assessment of the utility of these gene sets as potential biomarker panels would need to be validated in a much larger independent population, which was beyond the scope of this analysis.
Strengths and limitations
We are restricted in our ability to fully predict sPTL or categorize the underlying biological changes in women undergoing active sPTL due to study limitations. We compare laboring to nonlaboring controls, so changes we observe may be directly related to altered pathology leading to premature delivery or may represent systemic changes that occur during labor. Women in this cohort undergoing sPTL were administered corticosteroids prior to blood collection. While we characterized the effect of dexamethasone on transcription within monocyte-derived macrophages, we cannot conclude the differential genes identified in this analysis, including ADAMTS2, were not influenced by changes in glucocorticoid signaling directly related to corticosteroid treatment. Additionally, cases and controls were not matched on maternal ethnicity, socioeconomic status, or maternal age, which all may contribute to increased risk of PTB. Study strengths include its novelty as the first RNA sequencing analysis involving maternal blood, which provides enhanced resolution compared to microarrays and qPCR (quantitative PCR), and implementation of network-based approaches, which provide improved capability to identify dysregulated gene sets. We have quantified transcriptomics changes in blood, a readily accessible and minimally invasive biological tissue, which enhances clinical utility.
Conclusions
We have characterized transcriptional changes occurring within the understudied phenotype of sPTL, with ADAMTS2 expression emerging as a potential novel biomarker. The genes and gene sets described here may represent potential therapeutic targets. Further work is needed to validate in independent populations and integrate it with additional "omics." n References 
Glossary of terms
Affymetrix U133 array: This is a type of microarray used to measure gene expression, which provides quantitative coverage of the human genome (Affymetrix, Carlsbad CA) Benjamini-Hochberg P value: The Benjamini-Hochberg approach is applied to a list of P values to reduce the false discovery rate. The Benjamini-Hochberg method ranks the P values and calculates a new P value based on the gene's rank divided by the total number of genes. Differential rank conservation (DIRAC): This is a tool to perform analyses of comparative biological networks using relative gene expression. DIRAC rank orders gene expression as a proxy for the state of a predefined network. DIRAC creates a template rank ordering that is characteristic of each phenotype, and then generates a statistical score between e1 and 1 that determines which rank template is the better match for any given sample (positive scores indicate one class, and negative scores the other). In this way, DIRAC identifies sets of genes that exhibit significant changes in rankings between cases and controls. This rank template can be used to predict case/control status based on if the rank ordering of a sample better matches the rank template of cases or controls. Empirical Analysis of Digital Gene Expression Data in R (EdgeR): This is a popular R package distributed through Bioconductor that contains functions to perform differential expression analysis of RNA sequencing data. This package implements methodologies based on negative binomial distributions of the data.
Fisher exact test:
A statistical test used to identify if there are significant difference in contingency tables. Broadly, this can be used to identify differences in the association between 2 variables. Leave-one-out cross-validation: Cross-validation is a statistical approach used to define how the results of a statistical analysis will generalize to a given data set by partitioning the data into subsets, and using the statistical analysis model generated to predict outcomes in the left-out subset. leave-one-out cross-validation is an extension of this approach that uses the model generated by all but one of the samples to predict that remaining sample. In this way, the accuracy of the model can be tested by seeing how well it performs on classification of each of these samples. RMA normalization: Robust multiarray normalization is a background adjustment performed to summarize probe level expression data using a log scale linear additive model. It is specifically used with Affymetrix gene expression arrays.
Spearman correlation: This is a nonparametric test to measure the strength and association between 2 ranked lists. t Test: A statistical test used to identify if 2 sets of data are significantly different based on the Student t distribution under the null hypothesis.
Trimmed mean of M normalization: RNA sequencing data are count based and not normally distributed. Trimmed mean of M normalization is a simple and robust way to estimate expression by using a weighted trimmed mean that calculates a normalization factor based on mean gene expression, with the exception of the bottom 5% and top 30% of genes. This normalization factor is then used to scale the data so that they have a normal distribution. 
Flow diagram describing Ontario Birth Study participants and study design
Flow diagram describing numbers and eligibility criteria for larger Ontario Birth Study, as well as subset of 50 spontaneous preterm labor cases and term controls retrospectively selected from this larger population based on additional exclusion/inclusion criteria. Through our RNA sequencing pipeline, some samples were not included due to poor-quality RNA sequencing results. Transcriptomic changes after dexamethasone treatment in monocyte derived macrophages Transcriptomic changes after dexamethasone treatment in monocyte-derived macrophages (GSE16880). Differential expression after corticosteroid treatment was defined using t tests comparing expression at each individual time point to base time point as P < .05 adjusted for multiple comparisons through Benjamini-Hochberg method. A, Pie chart of expression characterization as described in table from 350 genes differentially expressed in whole blood and/or monocytes in our original data set. B, Histogram of number of genes with significant changes in expression at each time point (1, 2, 4, 10, 24 hours) compared to base. 
Expression of stem cell factor (SCF)-KIT signaling genes
Expression of 12 differently expressed genes in stem cell factor signaling pathway in A, peripheral monocytes and B, whole blood. Preterm (orange dots) and term (blue dots) samples, and mean expression (black line). 
